Erica Mann

Erica Mann is an experienced business executive who currently serves as an Independent Non-Executive Director on the board of ALS Limited.14 Here are some key details about her background and current roles:

Professional Experience

Erica Mann has over 30 years of experience in senior executive roles across complex, highly regulated, multi-channel and multi-product environments in the pharmaceutical, over-the-counter (OTC), and fast-moving consumer goods (FMCG) industries.16

Some of her notable past positions include:

• President and Head of Bayer's Consumer Health Division
• President and General Manager of Pfizer Nutrition
• Senior Vice President of Global Nutrition at Wyeth

She has held leadership roles in multiple countries including South Africa, Australia, New Zealand, Germany, Switzerland, and the United States.2

Current Board Positions

Erica Mann currently serves as an Independent Non-Executive Director on the boards of several prominent companies:

• ALS Limited (appointed March 1, 2024)16
• Kellanova (formerly Kellogg Company) (appointed February 2019)23
• DSM-Firmenich AG35
• Perrigo1

Expertise and Recognition

Mann brings extensive experience in:

• Global and emerging markets, particularly across Africa, China, Russia, and Brazil1
• Consumer health, nutrition, and pharmaceutical industries
• Corporate governance in multinational corporations

Her expertise has been recognized internationally, with Fortune naming her to the list of the 50 Most Powerful Women International in 2016 and 2017.2

Background

Erica Mann is a native of South Africa and a citizen of Australia.2 Her LinkedIn profile confirms her current role as a non-executive director at ALS, Kellanova, and DSM-Firmenich AG.3